Literature DB >> 22830373

British HIV Association guidelines for the management of HIV infection in pregnant women 2012.

G P Taylor1, P Clayden, J Dhar, K Gandhi, Y Gilleece, K Harding, P Hay, J Kennedy, N Low-Beer, H Lyall, A Palfreeman, P Tookey, S Welch, E Wilkins, A de Ruiter.   

Abstract

The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of human immunodeficiency virus (HIV)-positive pregnant women in the UK. The scope includes guidance on the use of antiretroviral therapy (ART) both to prevent HIV mother-to-child transmission (MTCT) and for the welfare of the mother herself, guidance on mode of delivery and recommendations in specific patient populations where other factors need to be taken into consideration,such as coinfection with other agents. The guidelines are aimed at clinical professionals directly involved with, and responsible for, the care of pregnant women with HIV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22830373     DOI: 10.1111/j.1468-1293.2012.01030_2.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  35 in total

1.  Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.

Authors:  A Bamford; A Turkova; H Lyall; C Foster; N Klein; D Bastiaans; D Burger; S Bernadi; K Butler; E Chiappini; P Clayden; M Della Negra; V Giacomet; C Giaquinto; D Gibb; L Galli; M Hainaut; M Koros; L Marques; E Nastouli; T Niehues; A Noguera-Julian; P Rojo; C Rudin; H J Scherpbier; G Tudor-Williams; S B Welch
Journal:  HIV Med       Date:  2015-02-03       Impact factor: 3.180

2.  Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.

Authors:  Tim R Cressey; Saik Urien; Edmund V Capparelli; Brookie M Best; Sudanee Buranabanjasatean; Aram Limtrakul; Boonsong Rawangban; Prapan Sabsanong; Jean-Marc Treluyer; Gonzague Jourdain; Alice Stek; Marc Lallemant; Mark Mirochnick
Journal:  J Antimicrob Chemother       Date:  2014-09-25       Impact factor: 5.790

3.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

4.  Implementation of a safer conception service for HIV-affected couples in South Africa.

Authors:  Sheree R Schwartz; Jean Bassett; Ian Sanne; Rebecca Phofa; Nompumelelo Yende; Annelies Van Rie
Journal:  AIDS       Date:  2014-07       Impact factor: 4.177

5.  Effects of rilpivirine, 17β-estradiol and β-naphthoflavone on the inflammatory status of release of adipocytokines in 3T3-L1 adipocytes in vitro.

Authors:  Shalini Behl; Abdu Adem; Arif Hussain; Jaipaul Singh
Journal:  Mol Biol Rep       Date:  2019-03-29       Impact factor: 2.316

6.  Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.

Authors:  Stein Schalkwijk; Rob Ter Heine; Angela Colbers; Edmund Capparelli; Brookie M Best; Tim R Cressey; Rick Greupink; Frans G M Russel; José Moltó; Mark Mirochnick; Mats O Karlsson; David M Burger
Journal:  J Antimicrob Chemother       Date:  2019-05-01       Impact factor: 5.790

7.  Prevention of vertical HIV transmission and management of the HIV-exposed infant in Canada in 2014.

Authors:  Ari Bitnun; Jason Brophy; Lindy Samson; Ariane Alimenti; Fatima Kakkar; Valerie Lamarre; Dorothy Moore; Christos Karatzios; Sandra Seigel; Laura Sauve; Wendy Vaudry; Mark H Yudin; Deborah Money
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-03       Impact factor: 2.471

Review 8.  Impact of earlier combination antiretroviral therapy on outcomes in children.

Authors:  Mark F Cotton; Helena Rabie
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

9.  Amniocentesis in the HIV-infected pregnant woman: Is there still cause for concern in the era of combination antiretroviral therapy?

Authors:  Nisha Andany; Michelle Letchumanan; Lise Bondy; Kellie Murphy; Mona R Loutfy
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 10.  HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Authors:  Nisha Andany; Mona R Loutfy
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.